RSV

Nirsevimab Effective for Protecting Infants From RSV Lower Respiratory Tract Disease

Physician’s Briefing

Nirsevimab Effective for Protecting Infants From RSV Lower Respiratory Tract Disease

30 Jul 2025

1 min read

Seniors With RSV-Linked Hospitalization Have Increased Cardiovascular Outcomes

Physician’s Briefing

Seniors With RSV-Linked Hospitalization Have Increased Cardiovascular Outcomes

24 Jul 2025

1 min read

35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab

Physician’s Briefing

35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab

22 Jul 2025

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com